Exposure‐response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components-Reference-Cited by-同舟云学术

Exposure‐response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components

Published:2019-06-17 Issue:8 Volume:85 Page:1710-1718
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Bastida Carla¹²^ORCID,Soy Dolors¹³,Ruiz‐Esquide Virginia⁴,Sanmartí Raimon⁴,Huitema Alwin D.R.²⁵

Affiliation:

1. Pharmacy Service, Division of Medicines, Hospital Clinic BarcelonaUniversitat de Barcelona Spain

2. Department of Pharmacy & PharmacologyNetherlands Cancer Institute Amsterdam The Netherlands

3. IDIBAPS Barcelona Spain

4. Arthritis Unit, Rheumatology Department, Hospital Clinic BarcelonaUniversitat de Barcelona Spain

5. Department of Clinical Pharmacy, University Medical CenterUtrecht University Utrecht The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13954

Reference35 articles.

1. Tocilizumab in the treatment of adult rheumatoid arthritis

2. RoActemra® SPC (Roche registration Limited) 2009.http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_‐_Product_Information/human/000955/WC500054890.pdf. Accessed March 15 2017.

3. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

4. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study;Cost Effectiveness and Resource Allocation;2024-02-14

2. Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study;Journal of Clinical Medicine;2023-11-17

3. A framework for precision “dosing” of mental healthcare services: algorithm development and clinical pilot;International Journal of Mental Health Systems;2023-07-05

4. A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis;BMC Rheumatology;2022-12-09

5. Pharmacokinetic/Pharmacodynamic Evaluation of a New Purine-2,6-Dione Derivative in Rodents with Experimental Autoimmune Diseases;Pharmaceutics;2022-05-19